Welcome to LookChem.com Sign In|Join Free

CAS

  • or

67313-10-4

Post Buying Request

67313-10-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-(6-AMINO-9H-PURIN-9-YL)-4-(BENZYLAMINO)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3-OL

    Cas No: 67313-10-4

  • No Data

  • No Data

  • No Data

  • FDC-Chemical
  • Contact Supplier

67313-10-4 Usage

Chemical structure

2-(6-amino-9H-purin-9-yl)-4-(benzylamino)-5-(hydroxymethyl)tetrahydrofuran-3-ol is a complex compound consisting of a purine ring and a tetrahydrofuran ring.

Purine ring

The purine ring contains an amino group at the 6-position, which may contribute to its potential biological activities.

Amino group at 6-position

The presence of an amino group at the 6-position of the purine ring can influence the compound's reactivity and interactions with other molecules.

Tetrahydrofuran ring

The compound also contains a tetrahydrofuran ring, which is a six-membered oxygen-containing heterocycle.

Benzylamino group at 4-position

A benzylamino group is attached to the tetrahydrofuran ring at the 4-position, which can affect the compound's solubility, stability, and biological activity.

Hydroxymethyl group at 5-position

The hydroxymethyl group at the 5-position of the tetrahydrofuran ring can participate in hydrogen bonding and other interactions, potentially affecting the compound's properties and activities.

Potential biological activities

Due to its structural features, 2-(6-AMINO-9H-PURIN-9-YL)-4-(BENZYLAMINO)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3-OL may exhibit biological activities that could be of interest for medicinal chemistry research.

Need for further investigation

The specific properties and potential applications of this compound would require additional experimental studies to be fully understood and characterized.

Check Digit Verification of cas no

The CAS Registry Mumber 67313-10-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,3,1 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 67313-10:
(7*6)+(6*7)+(5*3)+(4*1)+(3*3)+(2*1)+(1*0)=114
114 % 10 = 4
So 67313-10-4 is a valid CAS Registry Number.

67313-10-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 9-[3-(benzylamino)-3-deoxy-β-D-ribofuranosyl]adenine

1.2 Other means of identification

Product number -
Other names 2-(6-AMINO-9H-PURIN-9-YL)-4-(BENZYLAMINO)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3-OL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:67313-10-4 SDS

67313-10-4Relevant articles and documents

A new protecting group '3′,5′-O-sulfinyl' for xylo-nucleosides. A simple and efficient synthesis of 3′-amino-3′-deoxyadenosine (a puromycin intermediate), 2,2′-anhydro-pyrimidine nucleosides and 2′,3′-anhydro-adenosine

Takatsuki, Ken-Ichi,Yamamoto, Makoto,Ohgushi, Sumito,Kohmoto, Shigeo,Kishikawa, Keiki,Yamashita, Haruhiro

, p. 137 - 140 (2007/10/03)

We developed a new protecting group, the cyclic sulfite for the protection of the 3′,5′-dihydroxy group of nucleosides. Seven cyclic sulfites, 4a-c, 5a-b, and 6a-b were prepared in high yields from the corresponding xylo-uridines 1 and 2, and xylo-adenosines 3 with thionyl chloride, respectively. Synthesis of the puromycin intermediate 8 was carried out by deprotection of the sulfite moiety through an intramolecular cyclization of the 2′-α-carbamate 7.

Syntheses of puromycin from adenosine and 7-deazapuromycin from tubercidin, and biological comparisons of the 7-aza/deaza pair

Robins, Morris J.,Miles, Robert W.,Samano, Mirna C.,Kaspar, Roger L.

, p. 8204 - 8210 (2007/10/03)

Protection (05′) of 2′,3′-anhydroadenosine with tert-butyldiphenylsilyl chloride and epoxide opening with dimethylboron bromide gave the 3′-bromo-3′-deoxy xylo isomer which was treated with benzylisocyanate to give the 2′-O-(N-benzylcarbamoyl) derivative. Ring closure gave the oxazolidinone, and successive deprotection concluded an efficient route to 3′-amino-3′-deoxyadenosine. Analogous treatment ofthe antibiotic tubercidin {7-deazaadenosine; 4-amino-7-(β-D-ribofuranosyl)-pyrrolo[2,3-d]pyrimidine} gave 3′-amino-3′-deoxytubercidin. Trifluoroacetylation of the 3′-amino function, elaboration of the heterocyclic amino group into a (1,2,4-triazol-4-yl) ring with N,N′-bis-[(dimethylamino)methylene]hydrazine, and nucleophilic aromatic substitution with dimethylamine gave puromycin aminonucleoside [9-(3-amino-3-deoxy-β-D-ribofuranosyl)-6-(dimethylamino)purine] and its 7-deaza analogue. Aminoacylation [BOC-(4-methoxy-L-phenylalanine)] and deprotection gave puromycin and 7-deazapuromycin. Most reactions gave high yields at or below ambient temperature. Equivalent inhibition of protein biosynthesis in a rabbit reticulocyte system and parallel growth inhibition of several bacteria were observed with the 7-aza/deaza pair. Replacement of N7 in the purine ring of puromycin by "CH" has no apparent effect on biological activity.

High-yield synthesis of 3'-amino-3'-deoxynucleosides. Conversion of adenosine to 3'-amino-3'-deoxyadenosine

Samano,Robins

, p. 2329 - 2332 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 67313-10-4